VolitionRx Limited Earnings Per Share (Diluted)
VolitionRx Limited (VNRX) reported Earnings Per Share (Diluted) of -$0.85 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- VolitionRx Limited earnings per share, diluted for the quarter ending 2026-06-30 was -$0.85.
- VolitionRx Limited earnings per share, diluted for the quarter ending 2026-03-31 was -$0.97.
- VolitionRx Limited earnings per share, diluted for the quarter ending 2025-09-30 was -$0.05.
- VolitionRx Limited earnings per share, diluted for the quarter ending 2025-06-30 was -$1.22.
- VolitionRx Limited earnings per share, diluted for fiscal 2024 was -$0.31.
- VolitionRx Limited earnings per share, diluted for fiscal 2023 was -$0.50.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.85 10-Q · filed 2026-08-13 | -$1.80 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.97 10-Q · filed 2026-05-14 | |||||
| 2025-09-30 | -$0.05 10-Q · filed 2025-11-13 | -$0.17 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | -$1.22 10-Q · filed 2026-08-13 | -$0.06 10-Q · filed 2025-08-14 | -$2.35 10-Q · filed 2026-08-13 | -$0.12 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | -$1.12 10-Q · filed 2026-05-14 | -$0.06 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | -$0.31 10-K · filed 2025-03-31 | |||||
| 2024-09-30 | -$0.07 10-Q · filed 2025-11-13 | -$0.25 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | -$0.08 10-Q · filed 2025-08-14 | -$0.19 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | -$0.10 10-Q · filed 2025-05-15 | |||||
| 2023-12-31 | -$0.50 10-K · filed 2025-03-31 | |||||
| 2015-09-30 | -$0.16 10-Q · filed 2015-11-04 | -$0.39 10-Q · filed 2015-11-04 | ||||
| 2015-06-30 | -$0.10 10-Q · filed 2015-08-11 | -$0.23 10-Q · filed 2015-08-11 | ||||
| 2014-09-30 | -$0.44 10-Q · filed 2015-11-04 | -$0.56 10-Q · filed 2015-11-04 | ||||
| 2014-06-30 | $0.06 10-Q · filed 2015-08-11 | -$0.11 10-Q · filed 2015-08-11 | ||||
| 2013-06-30 | -$0.10 10-Q · filed 2014-08-01 | -$0.19 10-Q · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |